TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
Back to search
Official data from USPTO
NEURIMMUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
05/17/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
06/27/2022
Registration date
11/21/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
05/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
25
Owner location
CH
Examiner
LEASER, ANDREW
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Neurimmune Holding AG
Representatives
Janice Housey Litmus Law PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of nervous system diseasesinfectious diseasesneoplasmsimmune system diseasesendocrine and metabolic diseasescirculatory system diseaseseye diseases; veterinary preparations for the treatment of nervous system diseasesinfectious diseasesneoplasmsimmune system diseasesendocrine diseasesmetabolic diseasescirculatory system diseaseseye diseases; pharmaceutical preparations for immunotherapeutic usepharmaceutical agents for the elimination of tumorspharmaceutical preparations for the treatment of neurodegenerative diseasespharmaceutical preparationsimmunogens; pharmaceutical preparationsantibodies used for the testing of the disease; vaccines; diagnostic preparations for medical use in the form of epitopes for detecting protein abnormalities; pharmaceutical preparationssynthetic peptides used for the treatment of central nervous system diseasesmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; sanitary preparations for medical use; biocides; diagnostic preparations for medical or veterinary use; sanitary towels for hygiene purposes; dietetic foods for medical use; dietetic beverages for medical use; biological preparations for medical use in the form of protein antibodies directed against specific protein epitopes for use in the treatment of central nervous system diseasesmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunological diseasesinflammatory diseasesrespiratory diseasespsychological diseases; anti-bacterial preparationsantibacterial substances for medical useanti-bacterial pharmaceutical preparationsbio-pharmaceutical preparations for the treatment of cancer; protein food supplements
Class 42
Monitoringinspection and analysis of biologically active chemicals for quality control purposes; research in the field of pharmaceutical productscosmetics and foodstuffs for others; advisory and information services in the field of monitoring and inspection for the quality control and scientific analysis of biologically active chemicals; research in the field of medical treatment and medical methods; research in the field of biotechnology and antibodies; medical and scientific research in the field of clinical trial review and research with regard to medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical production for quality control purposes and for purposes of scientific research and research in the field of biology; software design; computer programming; software maintenance; design and development of computer hardware; software development; consultancy and providing of information with respect to quality control of pharmaceutical products; scientific research in the field of cancerous diseases; scientific research with respect to chemistry
Class 44
Medical services; medical services in the field of immunity; providing medical information; medical examinationsphysical examinations for medical purposes; pharmaceutical consulting related to the compounding of medicines; wellness and health-related consulting services in the fields of nutrition and diet; consultancy and providing of information in the field of sanitary careproviding of health information in connection with health; veterinary services; beauty salon services; animal care servicesveterinary care services; medical consulting services for hygiene in the field of care; medical consultancy and providing of medical information with respect to preparationadministration and dosing of pharmaceutical preparations; medical and pharmaceutical consulting services relating to the preparation of pharmaceutical prescriptions by pharmacists and administration of pharmaceuticals; providing medical information for medical staff and for patients in the form of compiled reports in the field of diagnosticprophylactic and therapeutic properties of medicines; drug testingsystematic testing of medicinal products for medical use
Publications
History of USPTO decisions and trademark events.
38 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/18/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/26/2024
FIMP
FINAL DISPOSITION PROCESSED
02/26/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/31/2023
RFNP
REFUSAL PROCESSED BY IB
07/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/08/2023
RFRR
REFUSAL PROCESSED BY MPU
06/08/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/18/2023
CNRT
NON-FINAL ACTION WRITTEN
04/17/2023
DOCK
ASSIGNED TO EXAMINER
04/11/2023
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
01/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/04/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/16/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/07/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/20/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/15/2022
Continuous trademark protection
Get notified about every new filing that threatens NEURIMMUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.